 TEL AVIV, Israel, May 12, 2021 PRNewswire -- Chemomab Therapeutics Ltd. Nasdaq: CMMB, a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, today announced that the companys CEO, Dr. Adi Mor will present a corporate update at Oppenheimers virtual Rare and Orphan Disease Summit on May 21 st, 2021. 